Press Releases

HOUSTON, March 4, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today issued a video letter to its shareholders from Chairman and Chief Executive Officer, Walter Klemp,&nbs

ANNAPOLIS, Md., March 4, 2020 /PRNewswire/ -- Vision Innovation Partners today announced that it has acquired Baltimore Eye Physicians, a leading ophthalmology practice with two locations (including one surgery center) in Baltimore, Maryland. The acquisition further expands Vision Innovation Partners' growing network of op

SOUTH SAN FRANCISCO, Calif., March. 4, 2020 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today announced proof of concept data for a next generation dual conjugated combination immunostimulatory

DUBLIN, March 4, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the publication of results from the phase 3 ENLIGHTEN-1 clinical trial of ALKS 3831 (olanzapine/samidorp

MADRID, March 4, 2020 /PRNewswire/ -- Results from a new clinical study demonstrate surprising capabilities for Pharmactive's potent affron® saffron extract. The study found beneficial effects of the commercial extract to support several parameters of sleep quality, including helping induce restorative sleep even at very low doses.

REHOVOT, Israel, March 4, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading company in leveraging computational biology to design novel products for life-science-based industries, announces today its financial results for the fourth quarter and full year, ending December 31, 2019. 

SAN DIEGO, March 4, 2020 /PRNewswire/ -- Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer molecular testing platform designed for point-of-care (POC) infectious disease diagnosis, today announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza clinical trial in

SEATTLE, March 4, 2020 /PRNewswire/ -- AGC Biologic

STOCKHOLM, March 4, 2020 /PRNewswire/ -- In the fight against the Corona virus, Bactiguard donates products for infection prevention to Chinese hospitals, at a market value of over 2 million SEK."To help fight the new corona virus (covid-19) and protect the most severely ill patients, we will donate products from Bactiguard's

BIRMINGHAM, Ala., March 4, 2020 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) will host its 2020 investor day today in New York City. Encompass Health President & Chief Executive Officer Mark Tarr will outline the integrated healthcare service provider's longer term business outlook for the Co